Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Gemphire Therapeutics Inc

TRADE

NASDAQ: GEMPHealthcare / Biotechnology / USA
1.40-0.15-9.68%Vol 531 8631Y Perf -83.61%
Aug 15th, 2018 12:03
BID1.39 ASK1.40
Open1.53 Previous Close1.55
Pre-Market- After-Trading-
 - -%  - -%
Target Price
7.00 
Analyst Rating
Moderate Buy 2.00
Potencial %
396.45 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)20 
Earnings Rating
Price Range Ratio 52wk %
5.38 
Earnings Date

Today's Price Range

1.361.54

 

52wk Range

0.8311.43

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-80.65%
3 Months
-72.07%
6 Months
-76.59%
1 Year
-83.61%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
GEMP1.40-0.1500-9.68
AAPL208.62-1.1300-0.54
GOOG1 214.08-28.0200-2.26
MSFT107.31-2.2500-2.05
XOM76.98-1.3300-1.70
WFC58.070.00000.00
JNJ129.640.14000.11
FB176.32-4.7900-2.64
GE12.19-0.1600-1.30
JPM113.62-1.0300-0.90
...

TickerPriceChg.%52 Week High
CMG521.515.71521.40
KMB115.614.03124.15
BSX34.652.8237.30
PCG43.742.1071.57
CLX144.812.09150.40
PGR63.531.9964.77
HCP26.781.9030.59
EIX68.201.8283.38
HSY100.391.81115.82
ARE126.741.80134.37
ED79.891.7489.70
LUV60.091.6966.99
HST20.601.5322.47
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.50
Current Ratio 5.60
Long Term Debt to Total Capital 0.27
Total Debt to Equity 0.49
Interest Coverage -
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.23
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.20
Cash Flow Per Share -2.52
Price to Tangible Book1.23
Book Value per Share1.46
Enterprise Value (in ths.)1 272
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -143.74
Return on Assets (5Y Avg) -
ROA last 12 Months -102.48
Return on Capital (5Y Avg) -
ROC last 12 Months -99.91
Return on invested Capital Q -32.17
Return on invested Capital Y-149.68
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.51-0.477.84
Q01 2018-0.59-0.581.69
Q04 2017-0.72-0.6312.50
Q03 2017-0.72-0.82-13.89
Q02 2017-0.80-0.747.50
Q01 2017-0.61-0.79-29.51
Q04 2016--0.78-
Q03 2016-0.28-0.56-100.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.579.52Positive
9/2018 QR-0.7417.78Positive
12/2018 FY-2.579.51Positive
12/2019 FY-2.6222.94Positive
Next Report Date13th Aug 2018
Estimated EPS Next Report-0.51
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume531 863
Shares Outstanding (in ths.)14 230
Trades Count849
Dollar Volume780 384
Avg. Volume386 642
Avg. Weekly Volume4 002 132
Avg. Monthly Volume1 340 623
Avg. Quarterly Volume796 679

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

60%40%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
3 (75.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
1 (25.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Strong Buy
1.25
Strong Buy
1.00

There are no comments yet.

News

x